Breast Cancer Clinical Trial

Molecular Imaging of Breast Cancer With Breast PET/CT

Summary

This study is a feasibility study to determine if a combined breast PET/CT scanner can image malignant functional activity while determining anatomical structure in the same clinical setting for patients with breast cancer. End-points of this study are whether women will accept the imaging position and timing, and whether functional properties of breast cancer can be imaged with this device. The secondary purpose of this study is to explore protocol parameters with a view to optimizing imaging performance whilst minimizing patient discomfort. Imaging results will be compared to histological samples to determine ground truth.

View Full Description

Full Description

PET is literally a molecular imaging modality. In monitoring the patient's response to a specific chemotherapeutic regime, baseline and subsequent PET/CT scans can be used to quantitatively determine the therapeutic effect of the regime, using the standard uptake value (SUV), a common metric in PET imaging. The breast PET/CT system will facilitate molecular imaging of breast cancer using a number of radiolabeled molecules, available both commercially (18-FDG) and from the research environment.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

- Normal Adult Volunteers

Female, at least 18 years of age
Ability to lie motionless for up to 20 minutes

Patient Volunteers

Female, at least 18 years of age
Diagnostic findings from prior mammography highly suggestive of invasive breast carcinoma (BI-RADS category 5)
Not pregnant or breast-feeding
Ability to lie motionless for up to 20 minutes

Exclusion Criteria:

Normal Adult Volunteers

Inability to understand the risks and benefits of the study

Patient Volunteers

Recent breast biopsy
Diagnostic findings from prior mammography highly suggestive of noninvasive ductal or lobular carcinoma
Uncontrolled diabetes
Diabetic and blood sugar level > 200 mg/dL
Positive urine pregnancy test or currently breast-feeding
Inability to understand the risks and benefits of the study

Study is for people with:

Breast Cancer

Phase:

Phase 1

Estimated Enrollment:

4

Study ID:

NCT00584753

Recruitment Status:

Terminated

Sponsor:

University of California, Davis

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

UC David Medical Center
Sacramento California, 95817, United States

How clear is this clinincal trial information?

Study is for people with:

Breast Cancer

Phase:

Phase 1

Estimated Enrollment:

4

Study ID:

NCT00584753

Recruitment Status:

Terminated

Sponsor:


University of California, Davis

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider